期刊文献+

稳定沉默STAT3的HPV16阳性宫颈癌细胞株的建立

Establishment of HPV16 Positive Cervical Cancer Cell Lines with Stable Silence of STAT3
下载PDF
导出
摘要 目的:建立针对人信号传导与转录激活因子3(STAT3)的小发夹RNA(shRNA)逆转录病毒表达载体,建立稳定感染的人乳头瘤病毒16(HPV16)阳性宫颈癌细胞系,以进一步探讨STAT3在HPV16阳性宫颈癌发生和发展中的作用。方法:设计合成3条靶向STAT3基因的小干扰RNA(siRNA),从中选择1条具有最佳干扰效果的siRNA,构建STAT3-shRNA载体pSUPERretro-puro-STAT3,用293FT细胞包装质粒产生STAT3 shRNA逆转录病毒,感染HPV16阳性的宫颈癌细胞株SiHa和CaSki细胞后,通过嘌呤霉素筛选2周,约3 d传代1次,建立稳定细胞株,稳定沉默STAT3的细胞株命名为SiHa/STAT3-sh和CaSki/STAT3-sh。通过实时定量逆转录聚合酶链反应(qRT-PCR)和蛋白质印迹(Westernblotting)分别从mRNA和蛋白水平检测STAT3的表达量。结果:经RT-PCR和Western blotting实验证实,在SiHa/STAT3-sh和CaSki/STAT3-sh细胞中,STAT3 mRNA的抑制率达99%以上(P<0.01),STAT3总蛋白抑制率达70%以上(P<0.01),磷酸化STAT3蛋白的抑制率达78%以上(P<0.01)。结论:稳定沉默STAT3的HPV16阳性宫颈癌细胞株建立成功。 Objective:Constructing retroviral vector of small hairpin RNA ( shRNA ) targeting human transducer and activator of transcription 3(STAT3),establishing stable infected HPV16 positive cervical cancer cell lines,to further explore the role of STAT3 in the development of HPV16 positive cervical cancer. Methods:Design and synthetise three siRNA sequences targeting STAT3,then select one with best gene interference effect,and construct STAT3-shRNA vector,pSUPERretro-puro-STAT3. The recombinant plasmid was transfected into packaging cell line 293FT and then infected into HPV16 positive cervical cancer cell line SiHa and CaSki cells. Cells were selected with puromycin for 2 weeks,passaged around every 3 days,and named with SiHa/STAT3-sh and CaSki/STAT3-sh. Expression of STAT3 was analyzed by quantitative reverse transcription polymerase chain reaction (qRT-PCR) and western blotting. Results:The knockdown of the expression of STAT3 mRNA was over 99%( P〈0 . 01 ) , that of the expression of STAT3 total protein was over 70% ( P〈0 . 01 ) and that of the expression of STAT3 phosphorylated protein was over 78% (P〈0.01) in both SiHa/STAT3-sh and CaSki/STAT3-sh cells. Conclusions:HPV16 positive cervical cancer cell lines with stable silence of STAT3 were successfully established.
出处 《国际妇产科学杂志》 CAS 2014年第4期366-369,F0003,共5页 Journal of International Obstetrics and Gynecology
关键词 宫颈肿瘤 DNA结合蛋白质类 人乳头瘤病毒16 RNA干扰 逆转录病毒科 Uterine cervical neoplasms Carcinoma DNA -binding proteins Human papillomavirus 16 RNA interference Retroviridae
  • 相关文献

参考文献11

  • 1Forman D,de Martel C,Lacey CJ,et al. Global burden of human papillomavirus and related diseases [J]. Vaccine, 2012,30(Suppl 5) : F12-F23.
  • 2Kamran MZ, Patil P, Gude RP. Role of STAT3 in cancer metastasis and translational advances [J]. Biomed Res Int, 2013,2013:421821. cervical carcinogenesis [J]. PLoS One, 2013,8(7 ) : e67849.
  • 3Miranda C,Fumagalli T,Anania MC,et al. Role of STAT3 in in vitro transformation triggered by TRK oncogenes [J]. PLoS One,2010, 5( 3 ) : e9446.
  • 4Shukla S,Shishodia G,Mahata S,et al. Aberrant expression and constitutive activation of STAT3 in cervical carcinogenesis: implications in high-risk human papillomavirus infection [J]. Mol Cancer,2010,9:282.
  • 5Quint6s-Cardama A, Verstovsek S. Molecular pathways : Jak/STAT pathway: mutations,inhibitors, and resistance [J]. Clin Cancer Res, 2013,19(8): 1933-1940.
  • 6Shukla S, Mahata S, Shishodia G, et al. Functional regulatory role of STAT3 in HPVl6-mediated.
  • 7沈青丽,林仲秋,叶明,何耀娟,郭凯敏.HPV16癌基因调节STAT3磷酸化和miR-21的表达[J].现代妇产科进展,2013,22(9):713-715. 被引量:4
  • 8吴维光,陈亚琼,陈晓.RNAi沉默STAT3基因对人宫颈癌SiHa细胞定植和侵袭的影响[J].国际妇产科学杂志,2010,37(5):367-369. 被引量:3
  • 9吴维光,陈亚琼,葛红雨,韩建秋,王勇梅.抑制STAT3基因表达对人宫颈癌HeLa细胞定植和侵袭的影响[J].肿瘤基础与临床,2010,23(1):13-16. 被引量:2
  • 10Mankan AK,Greten FR. Inhibiting signal transducer and activator of transcription 3 : rationality and rationale design of inhibitors [J]. Expert Opin Investig Drugs, 20! 1,20( 9 ) : 1263-1275.

二级参考文献43

  • 1范钰,张尤历,张宇川,吴莺,魏金文,程兆明,何亚龙,王银环,李华.siRNA敲除STAT3基因对结肠癌HCT116细胞侵袭的抑制[J].江苏大学学报(医学版),2007,17(1):46-48. 被引量:8
  • 2Haura EB ; Turkson J, Jove R. Mechanisms of disease: insights into the emerging role of signal transducers and activators of transcription in cancer[J]. Nat Clin Pract Oncol, 2005, 2(6) :315 -324.
  • 3Chen CL, Hsieh FC, Leblem JC, et al. Stat3 activation in human endametrial and cervical cancers [ J ]. Br J Cancer, 2007,96 ( 4 ) : 591 - 599.
  • 4Levy DE, Inghirami G. STAT3: a muhifaceted oncogene [ J]. Proc Natl Acad Sci USA, 2006, 103(27) : 10151 -10152.
  • 5Kortylewskl M, Yu H. Star3 as a potential target for cancer immunotherapy [J]. J Immunother, 2007, 30(2) :131 -139.
  • 6Huang C, Cao J, Huang KJ, et al. Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cells in vitro[J]. CancerSci, 2006, 92(2):1417-1423.
  • 7Allen D, Kenna PF, Palfi A, et al. Development of strategies for Conditional RNA interference [ J ]. J Gene Med, 2007,9 (4) :287 - 298.
  • 8Page C, Huang M, Jin X, et al. Elevated phosphorylation of AKT and Stat3 in prostate, breast, and cervical cancer cells[ J]. Int J Oncol, 2000,17(1) :23 -28.
  • 9Wang M, Zhang W, Crisostomo P, et al. STAT3 mediates bone marrow mesenchymal stem cell VEGF production [ J]. J Mol Cell Cardiol, 2007, 42(6) : 1009 - 1015.
  • 10Xie TX, Wei D, Liu M, et al. Stat3 activation regulates the expression of matrix metalloproteinase-2 and tumor invasion and metastasis [J]. Oncogene, 2004, 23(20):3550-3560.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部